Single-Use Bio Reactors Market Report 2026

Single-Use Bio Reactors Market Overview

• Single-Use Bio Reactors market size has reached to $6.18 billion in 2025 • Expected to grow to $16.28 billion in 2030 at a compound annual growth rate (CAGR) of 21.4% • Growth Driver: The Surge In Pharmaceutical Product Demand Fuels Growth Of The Single-Use Bioreactor Market • Market Trend: Technological Advancements Drive Competitive Edge In The Single-Use Bioreactors Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Single-Use Bio Reactors Market?

A single-use bioreactor is a bioreactor that has a disposable bag instead of a culture vessel. It permits processors to move to the utilization of disposable technologies, including single-use bags, in assembly steps that had been reserved for stainless steel gear. The main types of single-use bioreactors are stirred-tank SUBs, wave-induced SUBs, bubble-column SUBs, and other types. Stirred tank bioreactor designs that replicate traditionally stirred tank bioreactors have been introduced to the market, gaining more market adoption. The different types of molecules include vaccines, monoclonal antibodies, stem cells, and recombinant proteins and involve various cell types such as mammalian cells, bacteria, and yeast. The various applications involved are research and development, process development, and bioproduction. The several end-users include pharmaceutical and biopharmaceutical companies, contract research organizations (CRO), academic and research institutes, and contract manufacturing organizations (CMO).

What Is The Single-Use Bio Reactors Market Growth Forecast?

The single-use bio reactors market size is expected to see exponential growth in the next few years. It will grow to $16.28 billion in 2030 at a compound annual growth rate (CAGR) of 21.4%. The growth in the forecast period can be attributed to increasing investments in biologics manufacturing, rising adoption of continuous bioprocessing, growing demand for vaccine production capacity, expansion of personalized medicine pipelines, increasing focus on cost-efficient biomanufacturing. Major trends in the forecast period include increasing adoption of disposable bioprocessing systems, rising demand for flexible and scalable bioreactors, growing use of single-use systems in bioproduction, expansion of modular biomanufacturing facilities, enhanced focus on contamination risk reduction.

Global Single-Use Bio Reactors Market Segmentation

1) By Type: Stirred-Tank SUBs, Wave-Induced SUBs, Bubble-Column SUBs 2) By Molecule Type: Vaccines, Monoclonal Antibodies, Stem Cells, Recombinant Proteins 3) By Cell Type: Mammalian Cell, Bacteria, Yeast 4) By Application: Research And Development (R&D), Process Development, Bioproduction 5) By End User: Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations (CRO), Academic And Research Institutes, Contract Manufacturing Organizations (CMO) Subsegments: 1) By Stirred-Tank SUBs: Single-Use Stirred-Tank Bioreactors, Batch Stirred-Tank SUBs, Continuous Stirred-Tank SUBs 2) By Wave-Induced SUBs: Wave-Mixed Bioreactors, Disposable Wave Bioreactors 3) By Bubble-Column SUBs: Aerated Bubble-Column SUBs, Non-Aerated Bubble-Column SUBs

What Is The Driver Of The Single-Use Bio Reactors Market?

The increasing demand for pharmaceutical products is expected to drive the growth in the single-use bioreactors market going forward. Pharmaceutical products refer to scientifically formulated drugs and medical preparations designed to diagnose, treat, prevent, or manage diseases and health conditions while ensuring safety, efficacy, and quality. The increasing demand for pharmaceutical products is rising primarily due to the growing global burden of diseases, which is driving the need for more effective and accessible treatments, thereby accelerating drug consumption and healthcare utilization. Single-use bioreactors help pharmaceutical products by enabling faster, contamination-free, and highly flexible bioproduction processes that support efficient scaling and consistent product quality. For instance, in November 2024, according to a report published by the Italian Medicines Agency (AIFA), an Italy-based regulatory body, in 2023, Italy recorded an average daily consumption of 1,899 medicine doses per 1,000 inhabitants, with 69.7% supplied through the NHS and the remaining 30.3% bought directly by citizens. Therefore, the increasing demand for pharmaceutical products is driving the single-use bioreactors market.

Key Players In The Global Single-Use Bio Reactors Market

Major companies operating in the single-use bio reactors market are Sartorius AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Eppendorf AG, ABEC Inc., PBS Biotech Inc., Infors AG, Solaris Biotechnology Srl, Cellexus International Ltd., Getinge AB, Kuhner AG, ZETA Holding GmbH, BBI-Biotech GmbH, Tofflon Science And Technology Group Co Ltd, Bioengineering AG, H.E.L Group Ltd, Electrolab Biotech Ltd, GEA Group AG

Global Single-Use Bio Reactors Market Trends and Insights

Major companies operating in the single-use bioreactor market are developing technologically advanced products such as X-platform bioreactors to gain a competitive advantage. X-platform bioreactors are designed to meet today's and future single-use upstream bioprocessing needs, working in tandem with the Cytiva Bioreactor Scaler to optimize scaling without the need for trial and error. For instance, in April 2023, Cytiva Bioscience Holding Ltd., a U.S.-based life sciences company, introduced X-platform bioreactors designed to enhance efficiency in single-use upstream bioprocessing. These bioreactors, initially available in sizes ranging from 50 to 200 liters, come equipped with the Figurate automation solution software. They are engineered to improve process efficiency by increasing production capacity, enhancing ergonomics, and streamlining supply chain operations.

What Are Latest Mergers And Acquisitions In The Single-Use Bio Reactors Market?

In June 2023, Donaldson Company Inc., a US-based vertically integrated filtration company, acquired Univercells Technologies for $136 million. With this acquisition, Donaldson Company Inc., aims to further broaden its product portfolio, ensuring the delivery of a comprehensive and distinctive range of products to customers as part of its life sciences strategy. Univercells Technologies is a Belgium-based biotechnology company specializing in single-use bioprocessing and bioreactor products.

Regional Outlook

North America was the largest region in the single use bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Single-Use Bio Reactors Market?

The single-use bioreactors market consists of sales of stirrer single-use bioreactors and rocker single-use bioreactors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.